Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023

SELL
$0.51 - $17.1 $102 - $3,420
-200 Reduced 1.45%
13,575 $9,000
Q3 2022

Nov 03, 2022

BUY
$1.01 - $17.0 $606 - $10,200
600 Added 4.55%
13,775 $21,000
Q1 2022

May 03, 2022

SELL
$1.4 - $5.15 $560 - $2,060
-400 Reduced 2.95%
13,175 $19,000
Q4 2021

Feb 10, 2022

SELL
$4.27 - $6.97 $5,550 - $9,061
-1,300 Reduced 8.74%
13,575 $71,000
Q2 2021

Aug 09, 2021

SELL
$6.81 - $9.23 $4,085 - $5,538
-600 Reduced 3.88%
14,875 $120,000
Q1 2021

May 11, 2021

BUY
$7.99 - $15.0 $6,152 - $11,550
770 Added 5.24%
15,475 $129,000
Q4 2020

Feb 03, 2021

SELL
$7.04 - $11.7 $76,876 - $127,763
-10,920 Reduced 42.61%
14,705 $111,000
Q3 2020

Nov 05, 2020

BUY
$9.98 - $18.04 $8,283 - $14,973
830 Added 3.35%
25,625 $273,000
Q2 2020

Aug 10, 2020

BUY
$7.49 - $15.16 $62,391 - $126,282
8,330 Added 50.59%
24,795 $376,000
Q1 2020

May 05, 2020

SELL
$4.62 - $18.74 $18,359 - $74,472
-3,974 Reduced 19.44%
16,465 $137,000
Q4 2019

Feb 11, 2020

SELL
$14.6 - $18.13 $5,927 - $7,360
-406 Reduced 1.95%
20,439 $345,000
Q2 2019

Jul 31, 2019

SELL
$17.79 - $22.88 $7,116 - $9,152
-400 Reduced 1.88%
20,845 $477,000
Q4 2018

Feb 07, 2019

SELL
$10.42 - $21.94 $49,495 - $104,215
-4,750 Reduced 18.27%
21,245 $244,000
Q3 2018

Oct 12, 2018

SELL
$20.4 - $24.6 $11,220 - $13,530
-550 Reduced 2.07%
25,995 $597,000
Q2 2018

Jul 30, 2018

SELL
$19.02 - $24.95 $4,564 - $5,988
-240 Reduced 0.9%
26,545 $592,000
Q1 2018

May 11, 2018

BUY
$22.55 - $29.9 $3,382 - $4,485
150 Added 0.56%
26,785 $612,000
Q4 2017

Jan 30, 2018

SELL
$18.0 - $30.0 $2,700 - $4,500
-150 Reduced 0.56%
26,635 $698,000
Q3 2017

Oct 23, 2017

SELL
$21.1 - $25.15 $4,220 - $5,030
-200 Reduced 0.74%
26,785 $601,000
Q2 2017

Aug 07, 2017

BUY
N/A
26,985
26,985 $738,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Cutter & CO Brokerage, Inc. Portfolio

Follow Cutter & CO Brokerage, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.